LACY MCMILLON: Open Payments
NPI 1316321748 · BANDERA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$374 in 12 payments from 6 companies in 2025. Trend: 2023 $132 · 2024 $209 · 2025 $374
Food & beverage: $374
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 7 | $279 |
| Lilly USA, LLC | 1 | $25 |
| Currax Pharmaceuticals LLC | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: DAXXIFY, DAXI, MOUNJARO, CONTRAVE, DYSPORT, Wegovy, XYOSTED.
Industry payments across TX — which companies pay providers there.
